Back to News
Market Impact: 0.4

SpaceX Went From $150 to $225 and Back in Under 2 Weeks -- Here's the Math That Explains Every Dollar of That Move

M&A & RestructuringCompany FundamentalsMarket Technicals & FlowsAnalyst InsightsCapital Returns (Dividends / Buybacks)Regulation & Legislation
SpaceX Went From $150 to $225 and Back in Under 2 Weeks -- Here's the Math That Explains Every Dollar of That Move

SpaceX’s IPO float was only 4.24% on June 12 and is set to expand as staggered lockups expire, with the current float of ~555.6M shares potentially multiplying over the next year. The stock’s first-week surge to ~$225 reversed quickly back toward ~$150, attributed to (1) high valuation (~$2T market cap, ~110x 2025E revenue of $18.6B) and (2) dilution to fund its $60B Cursor acquisition with stock. As insider selling windows open (early window after the first earnings report; CEO/major holders locked for 366 days), further supply could pressure the shares if fundamentals don’t match the valuation.

Analysis

This is a classic post-IPO mechanics story, not a clean fundamentals re-rating. The setup is dominated by float math: when tradable supply is tiny relative to demand, price discovery can overshoot; once insiders and pre-IPO holders have a path to distribute, the same scarcity premium can unwind quickly. The market is effectively pricing a “perfect scarcity” state today, while the forward curve is really a sequence of supply releases over the next several quarters. The first-order risk is not simply that valuation is high; it is that future capital needs and stock-based consideration create a persistent seller overhang. That matters because momentum buyers are most sensitive to dilution narratives, and the fastest downside usually appears after the first credible window where shares can hit the tape in size. If the company needs to use equity for M&A or employee retention, each such event raises the effective free-float and lowers the scarcity premium. The consensus is missing how quickly this can transition from a “can’t get enough shares” story to a “who is next to sell?” story. That is a 1-3 month catalyst path, with the bigger structural test over 6-18 months when the float becomes meaningfully larger and the stock must stand on earnings power rather than technicals. The thesis is falsified if post-lockup selling is absorbed without price damage and the company raises guidance enough to offset dilution on a per-share basis.